Latest Global Markets News

Alcoa Corporation reported robust fourth quarter and full year 2024 results, driven by higher alumina and aluminum prices, operational gains, and key strategic initiatives including the Alumina Limited acquisition.

Element 25 Limited has announced a 107% increase in Ore Reserves at its Butcherbird Manganese Project in Western Australia, now supporting an 18.3-year mine life at 1.1Mtpa production. This milestone underpins the company’s strategic expansion into battery-grade manganese supply for the EV market.

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.

Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.

Sovereign Metals Limited has released an Optimised Pre-Feasibility Study for its Kasiya Rutile-Graphite Project, reaffirming its position as a future global leader in critical minerals production with robust economics and operational improvements.

First Graphene Limited strengthens its financial footing with a UK R&D tax rebate and expands its global footprint through new distribution agreements in India and Brazil.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Wellnex Life has negotiated a delayed and reduced-cost payment arrangement for its Pain Away acquisition, aligning with its upcoming London Stock Exchange dual listing plans. The move supports the company’s growth momentum following record revenues from Pain Away.

Qoria Limited reports robust December quarter results for FY2025, driven by strong ARR growth, expanding global reach, and strategic AI innovations that promise to accelerate future growth.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.

Montaka Global Long Only Equities Fund has announced a distribution of 11.30 cents per unit for the half-year ending 31 December 2024, continuing its commitment to delivering steady income alongside capital growth.